Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKesson
Chinese Patent Office
Merck
Healthtrust
Harvard Business School

Generated: August 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201971

  Try a free trial


See Plans and Pricing

« Back to Dashboard

NDA 201971 describes RASAGILINE MESYLATE, which is a drug marketed by Alkem Labs Ltd, Apotex Inc, Micro Labs, Mylan, Orchid Hlthcare, Sandoz Inc, and Watson Labs Inc, and is included in seven NDAs. It is available from five suppliers. Additional details are available on the RASAGILINE MESYLATE profile page.

The generic ingredient in RASAGILINE MESYLATE is rasagiline mesylate. There are eighteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the rasagiline mesylate profile page.
Summary for 201971
Tradename:RASAGILINE MESYLATE
Applicant:Mylan
Ingredient:rasagiline mesylate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 201971
Mechanism of ActionMonoamine Oxidase Inhibitors
Suppliers and Packaging for NDA: 201971
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 201971 ANDA Mylan Pharmaceuticals Inc. 0378-1270 0378-1270-93 30 TABLET in 1 BOTTLE, PLASTIC (0378-1270-93)
RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 201971 ANDA Mylan Pharmaceuticals Inc. 0378-1271 0378-1271-93 30 TABLET in 1 BOTTLE, PLASTIC (0378-1271-93)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 0.5MG BASE
Approval Date:May 15, 2017TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 1MG BASE
Approval Date:May 15, 2017TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Fuji
Harvard Business School
Moodys
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.